JP2019531100A5 - - Google Patents

Download PDF

Info

Publication number
JP2019531100A5
JP2019531100A5 JP2019542759A JP2019542759A JP2019531100A5 JP 2019531100 A5 JP2019531100 A5 JP 2019531100A5 JP 2019542759 A JP2019542759 A JP 2019542759A JP 2019542759 A JP2019542759 A JP 2019542759A JP 2019531100 A5 JP2019531100 A5 JP 2019531100A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
amino acid
construct
sequences shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019542759A
Other languages
English (en)
Japanese (ja)
Other versions
JP7181208B2 (ja
JP2019531100A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2017/051253 external-priority patent/WO2018072031A1/en
Publication of JP2019531100A publication Critical patent/JP2019531100A/ja
Publication of JP2019531100A5 publication Critical patent/JP2019531100A5/ja
Priority to JP2022183528A priority Critical patent/JP2023025066A/ja
Application granted granted Critical
Publication of JP7181208B2 publication Critical patent/JP7181208B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019542759A 2016-10-21 2017-10-20 ワクチン構築物およびブドウ球菌感染症に対するその使用 Expired - Fee Related JP7181208B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022183528A JP2023025066A (ja) 2016-10-21 2022-11-16 ワクチン構築物およびブドウ球菌感染症に対するその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662411120P 2016-10-21 2016-10-21
US62/411,120 2016-10-21
PCT/CA2017/051253 WO2018072031A1 (en) 2016-10-21 2017-10-20 Vaccine constructs and uses thereof against staphylococcus infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022183528A Division JP2023025066A (ja) 2016-10-21 2022-11-16 ワクチン構築物およびブドウ球菌感染症に対するその使用

Publications (3)

Publication Number Publication Date
JP2019531100A JP2019531100A (ja) 2019-10-31
JP2019531100A5 true JP2019531100A5 (enExample) 2020-11-26
JP7181208B2 JP7181208B2 (ja) 2022-11-30

Family

ID=62018642

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019542759A Expired - Fee Related JP7181208B2 (ja) 2016-10-21 2017-10-20 ワクチン構築物およびブドウ球菌感染症に対するその使用
JP2022183528A Withdrawn JP2023025066A (ja) 2016-10-21 2022-11-16 ワクチン構築物およびブドウ球菌感染症に対するその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022183528A Withdrawn JP2023025066A (ja) 2016-10-21 2022-11-16 ワクチン構築物およびブドウ球菌感染症に対するその使用

Country Status (24)

Country Link
US (2) US11324815B2 (enExample)
EP (1) EP3529260A4 (enExample)
JP (2) JP7181208B2 (enExample)
KR (1) KR20190082229A (enExample)
CN (1) CN109843910A (enExample)
AR (1) AR109847A1 (enExample)
AU (2) AU2017346974B2 (enExample)
BR (1) BR112019007796A2 (enExample)
CA (1) CA3037070A1 (enExample)
CL (1) CL2019001048A1 (enExample)
CO (1) CO2019005169A2 (enExample)
CR (1) CR20190249A (enExample)
DO (1) DOP2019000102A (enExample)
IL (1) IL265869A (enExample)
MX (2) MX2019004539A (enExample)
MY (1) MY195369A (enExample)
NZ (1) NZ751880A (enExample)
PE (1) PE20191320A1 (enExample)
PH (1) PH12019500843A1 (enExample)
RU (2) RU2022100889A (enExample)
SG (2) SG11201901483QA (enExample)
TW (1) TW201819402A (enExample)
UY (1) UY37448A (enExample)
WO (1) WO2018072031A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113777317A (zh) * 2020-06-09 2021-12-10 首都医科大学附属北京世纪坛医院 尿液主穹隆蛋白及其多肽片段在烧伤中的应用
US20220185852A1 (en) * 2020-12-11 2022-06-16 Bayer Animal Health Gmbh Methods and compositions for improved production of an antigen for use in an s. aureus vaccine
WO2026014994A1 (ko) * 2024-07-12 2026-01-15 주식회사 더윤헬스텍 젖소 유방염 유래 대장균 또는 황색 포도알균 변이주 및 이를 포함하는 백신 조성물
US12161970B1 (en) 2024-08-09 2024-12-10 Jiaxing Research Institute, Zhejiang University CO2 desorption system suitable for limited space in complex sailing region and flexible control method

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662517B2 (ja) 1985-01-07 1994-08-17 シンテツクス(ユー・エス・エイ)インコーポレイテツド 置換アルキルートリ置換アンモニウム界面活性剤
US6228844B1 (en) 1991-11-12 2001-05-08 Vical Incorporated Stimulating vascular growth by administration of DNA sequences encoding VEGF
US6380370B1 (en) 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US7060458B1 (en) 1997-08-14 2006-06-13 Wyeth Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
CN1569893A (zh) 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 金葡菌毒力因子调控蛋白的抗原表位及其模拟表位和用途
RU2419628C2 (ru) * 2004-09-22 2011-05-27 ГлаксоСмитКлайн Байолоджикалз с.а. Иммуногенная композиция для применения в вакцинации против стафилококков
BRPI0516974A (pt) * 2004-10-21 2008-09-30 Wyeth Corp composição imunogênica compreendendo um polipeptìdeo; um método para induzir uma resposta imune contra staphylococcus epidermidis; um método para induzir uma resposta imune contra staphylococcus aureus; um método para a detecção e/ou identificação de staphylococcus epidermidis; um método para a detecção e/ou identificação de anticorpos para staphylococcus epidermidis
KR100729954B1 (ko) 2004-12-01 2007-06-20 주식회사 엘지생명과학 Sec1 변이 단백질의 제형 및 그것의 제형화 방법
CA2667788A1 (en) 2006-10-30 2008-12-18 The University Of Western Ontario Staphylococcus aureus specific anti-infectives
NZ614557A (en) * 2009-03-23 2015-03-27 Epitopix Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
EP2419129A2 (en) 2009-04-14 2012-02-22 Novartis AG Compositions for immunising against staphylococcus aerus
PL2547361T3 (pl) 2010-03-17 2021-02-22 Socpra - Sciences Et Génie, S.E.C. Bakteryjne składniki szczepionek pochodzące ze staphylococcus aureus i ich zastosowania
EP3777885A1 (en) 2011-06-19 2021-02-17 New York University Methods of treating and preventing staphylococcus aureus infections and associated conditions

Similar Documents

Publication Publication Date Title
SI2280721T1 (en) Indoleamine 2, 3-dioxygenase based immunotherapy
SI2707393T1 (en) Fusion proteins and combined vaccines comprising protein E and AH haemophilus influenzae
JP2008538183A5 (enExample)
JP2008525033A5 (enExample)
JP2015522576A5 (enExample)
RU2016146801A (ru) Вакцинная композиция против инфекции, вызванной streptococcus suis
RU2007139915A (ru) Haemophilus influenzae типа в
IL276210B2 (en) Mers-cov vaccine
JP2014507146A5 (enExample)
JP2015500827A5 (enExample)
JP2021519597A5 (enExample)
JP2012115277A5 (enExample)
JP2015514132A5 (enExample)
CA2380833A1 (en) Proteins derived from white spot syndrome virus and uses thereof
JP2024508683A5 (enExample)
JP2013520487A5 (enExample)
JP2013523718A5 (enExample)
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
RU2022100889A (ru) Вакцинные конструкты и их применения против инфекций стафилококка
CN104844712A (zh) 肺炎链球菌蛋白抗原及其制备方法和应用
JP2017513849A5 (enExample)
JP2023522154A5 (enExample)
JP2019526261A5 (enExample)
TW201808985A (zh) 衍生自精胺酸密集區之經修飾抗菌胜肽
JP2009527510A5 (enExample)